Summary Bracken toxicity to both domestic and laboratory animals is well established and tumours are formed when rodents are treated with either bracken extracts or bracken spores. In this study we have administered bracken spores and extract to mice in order to investigate whether such exposure leads to the formation of DNA adducts. DNA, isolated from the upper gastrointestinal tract and liver, was digested to 3'-nucleotides. Adducts were extracted with butanol, 32P-post-labelled, separated by thin layer chromatography (TLC) and visualised and quantified using storage-phosphor technology. A cluster of adducts was clearly seen in the DNA of the upper gastrointestinal tract, but not liver, 5 and 24 h after treatment with bracken extract or bracken spores. These adducts were not observed in DNA extracted from vehicle-treated animals. Whereas, after 5 h adduct levels in extract and spore-treated animals were similar, after 24 h adduct levels in the extracttreated animals had diminished by > 75%, but levels in spore-treated animals remained similar to those found after 5 h. This suggests that the DNA-reactive compounds were being released slowly from the spores, even though the spores had been sonicated before administration. Adducts were also quantified after the addition of an internal standard (deoxyinosine 3'-monophosphate) by comparing the amount of label incorporated into the adducts with that found in a known amount of the internal standard. Adduct levels using this internal standard approach were similar to those found by direct measurement of radioactivity incorporated into the adduct, indicating that the labelling of adducts was quantitative. We have tried, unsuccessfully, to synthesise ptaquiloside, the principal carcinogenic component present within bracken. However, similar patterns of adducts were observed when two other compounds, (1-(4-chlorophenyl sulphonyl)-l-cyclopropane carbonitrile and 3-cyclopropylindeno [1,2-c] pyrazol-4-(0-methyl)oxime), which both contain a cyclopropyl ring, were administered to mice. The adducts detected in bracken-treated animals may, thus, have arisen from ptaquiloside but, whether these adducts arise directly from the compounds and bracken spores/extract themselves or via an indirect mechanism, remains to be determined. As bracken-induced DNA adducts are detectable in rodent tissues by a 32P-post-labelling procedure commonly employed to investigate DNA damage in human populations, it may prove possible to apply such approaches to determine human exposure.
The toxicity of bracken and bracken extracts giving rise to various disease syndromes of domestic animals, including carcinomas of the bladder in cows, is well established (Evans, 1984) . Bracken fern is also carcinogenic to laboratory animals (Evans and Mason, 1965) and, since then, the feeding of fresh or dry bracken fern, or the administration of its aqueous and alcohol extracts, has produced cancers at numerous tissue sites in cows, rats, mice, hamsters, toads and quails, giving rise to a variety of soft tissue malignancies, leukaemias and osteosarcomas (Evans and Mason, 1965; Evans, 1984; IARC, 1986) . Fresh bracken spores, too, are carcinogenic, producing gastric tumours and leukaemias (Evans, 1987) . The carcinogenic principle(s) of bracken can be transmitted via milk, as demonstrated when milk from bracken-fed cows was used to supplement the diet of mice (Villalobos-Salazar et al., 1990) .
In humans, bracken intake has been associated with elevated rates of oesophageal cancer in Japan [2.1-fold in men and 3.7-fold in women (Hirayama, 1979) ] and oesophageal and gastric cancer in Brazil (Marliere et al., 1995) . Increased gastric cancer rates have also been observed in North Wales where childhood bracken exposure was associated with an elevated relative risk of 2.3 among people living in small farming communities (Galpin et al., 1990) . Similarly in Costa Rica, increased risks of 2.3-fold (men) and 6.3-fold (women) were associated with mountainous regions where bracken grows prolifically, compared with those of the low lands, which are essentially bracken free (VillalobosSalazar et al., 1989) . In the UK, bracken consumption is rarely practised and, with the overall reduction in the use of bracken fern for animal bedding and the lapsed practice of the domestic use of bracken as a bedding material [e.g. the so-called Channel Island greenbed (Lenfestey, 1972/73) ], contact with bracken dusts is a vanishing problem. However, in common with many regions of the world, the advance of bracken cover [in the UK up by an average of 1% per annum and locally up to 30% (Taylor, 1986) ] may lead to an increased exposure to bracken spores during the late summer, particularly in those years when sporulation rates may be very high.
Bracken contains a number of toxic compounds, of which ptaquiloside is thought to be the principal carcinogenic compound. Ptaquiloside administration alone causes tumours in experimental animals (Hirono et al., 1987) . At physiological pH, ptaquiloside is converted to an unstable dienone (with the liberation of D(+) glucose), containing a highly reactive cyclopropyl group, which can react rapidly with amino acids, nucleosides and nucleotides and DNA (Ojika et al., 1987; . Reactions were observed at the N3 and N7 atoms of purines, the exocyclic oxygen atom of guanine and with the phosphate in DNA. Strand breaks also arise from the spontaneous cleavage of adducts at the N3 of adenine (principally), but also N7 of guanine (Kushida et al., 1994) . The spectrum of base damage and intrinsic instability caused by ptaquiloside thus resembles that of the classical alkylating agents (Saffhill et al., 1985) and the formation of these adducts may result in the carcinogenic action of ptaquiloside.
Correspondence: AC The adducted nucleotides were 32P-post-labelled for 1 h at 37°C in 30 mM Tris-HCl (pH 9.5) containing 10 mM magnesium chloride, 10 mM DTT, 1 mM spermidine, 2.9 jgM ATP (total concentration) using 2.5 units T4 PNK and 40 , uCi 32P-y-ATP in a total volume of 10 ,ul. Table I . Figure 2 . cResults in brackets are for those determined using an internal standard method for determining adduct levels.
Quantitation of normal nucleotides
To determine normal levels of nucleotides released, 10 ug aliquots of the same DNA digest were treated with alkaline phosphatase to give nucleotides that were then quantified by HPLC (Cooper et al., 1992) .
Adduct quantitation TLC plates were dried, wrapped in plastic wrap and exposed to a phosphor screen (Molecular Dynamics, Sunnyvale, CA, USA) for up to 48 h. Sample visualisation was carried out using a Molecular Dynamics 425S phosphorimager at 176 gm resolution and volume quantitation was carried out using Imagequant software (Molecular Dynamics). Background determination for each individual image was carried out by calculating the average of all pixel values in the outline of the object.
In the absence of an internal standard, adducts were quantified by comparing the signal with that of known amounts of 32p spotted onto the same TLC plates and exposed together on the same phosphor screen for up to 48 h. The amounts of adducts detected were then quantified by determining the (adduct signal / 32p signal) ratio and assuming that the adduct was labelled quantitatively. When the internal standard was added, it was found that the response of the phosphor screens to the signal from the internal standard was linear only for a relatively short period of time (< 5 h). It was thus not possible to compare directly the signal from the internal standard with that from the adduct over an extended period (48 h). A standard curve, for which the phosphor screen response was linear for up to 48 h, was then prepared by diluting stock [32P]-y-ATP between 100 and 106 times. The same standard curve was then exposed to each ID plate (containing the internal standard) and each Randerath plate (containing the adducts) for 2 and 48 h respectively. Hence, the total amount of adduct present was equal to (adduct signal)/ (standard signal 48 h) x (standard signal 2 h)/pdIp signal) x 400 fmol (to account for differences in the amounts spotted on the different plates). In the absence of chemically synthesised adduct standards, we have assumed that the adduct was labelled at the same efficiency as the internal standard. Adduct levels are expressed as nmol adducts detected per mol of dGuo released (as determined by HPLC).
Results
A cluster of adducts, not present in the vehicle control, was clearly seen in the analyses of the butanol extracts from the digests of DNA from the upper gastrointestinal tract obtained 5 and 24 h after treatment with bracken extract (Figure 2) . Furthermore, a similar adduct pattern was observed in the DNA of those animals treated with bracken spores. Although there appeared to be a number of minor DNA adducts, three adducts (1 -3; Figure 2a ) were consistently observed and therefore quantified (Table I) . After 5 h, adduct levels in extract-and spore-treated animals were similar (mean levels ranging from 1.1 to 6.6 nmol mol-' dGuo) but, whereas after 24 h adduct levels in the extract-treated animals had diminished by >75%, levels in spore-treated animals were similar to those found after 5 h. This suggests that the DNA reactive compound(s) was being released slowly from the spores, even though the spores had been sonicated before administration. Liver DNA from treated mice did not exhibit the same pattern of adducts, but only adducts that were detected in both control and treated animals (data not shown).
The levels of bracken-induced adducts were also quantified after the addition of an internal standard (dIp) to account for variations in labelling efficiency. Figure 3 clearly demonstrates that pdlp could be separated simply by onedimensional chromatography from contaminating nucleotides and residual ATP. We found that quantitative labelling of dIp in the butanol extract could be obtained only when samples of <4,g DNA were digested and extracted. With increasing amounts of DNA, higher levels of residual nucleotides resulted in suboptimal labelling of dIp. Results for the quantitation of adduct levels using the internal standard approach were similar to those found in the absence of the dIp, indicating that quantitative labelling of the adducts had occurred in both the presence and absence of the standard. There appeared to be no differences in the variation of results obtained. As part of this work, we have prepared a number of compounds on the route to a synthesis of ptaquiloside. This synthesis has so far been unsuccessful owing to the instability of the cyclopropane ring during the multistep synthesis. However, treatment of mice with 1-(4-chlorophenyl sulphonyl)-l-cyclopropane carbonitrile and 3-cyclopropylindeno [1,2-c]pyrazol-4-(O-methyl)oxime resulted in the formation of adducts that were detectable in the DNA of the upper gastrointestinal tract (Figure 4 ). The adduct pattern was similar to those seen with bracken spores and bracken extract: preliminary experiments indicated that these adducts co-chromatographed with those adducts derived from bracken spores or extract using the same urea-based solvent systems or when using ammoniumn hydroxide/isopropanol as D4 (Beach and Gupta, 1992) .
Discussion
In this study we have demonstrated that DNA adducts arising from exposure to bracken extract or bracken spores can be detected in the upper gastrointestinal tract of mice by 32P-post-labelling. As ptaquiloside is thought to be the principal carcinogenic component in bracken (Hirono et al., 1987) and reacts directly with nucleotides in vitro (Ojika et al., 1987) , these DNA adducts, detected by 32P-post-labelling, may result from the interaction of an unstable dienone, formed by the breakdown of ptaquiloside, with DNA. Their identity is as yet unknown, but as T4-PNK only phosphorylates adducts with a bulky substituent at the N7 position of guanine poorly (Koivisto and Hemminki, 1990) , an adduct at the 7-guanine position would probably not have been detected. The N3 adenine and N7 guanine ptaquiloside adducts identified previously (Kushida et al., 1994) spontaneously depurinate in vitro with t1/2 of 18 and 40 h respectively. As more than 75% of the adduct levels present at 5 h, in mice treated with bracken extract, had been removed by 24 h, the adducts detected in this study were probably not these N3 and N7 modifications, unless these lesions are removed by active repair processes as is the case with N3 and N7 methylguanine adducts (Saffhill et al., 1985) .
In order to generate the appropriate marker compounds and so to provide definitive proof that these adducts arise from ptaquiloside, we have tried to synthesise ptaquiloside itself, but this has proved difficult owing to the instability of the cyclopropyl ring (Ojika et al., 1987) . Two other compounds containing a cyclopropyl ring, namely 1-(4-chlorophenyl sulphonyl)-1-cyclopropane carbonitrile and 3-cyclopropylindeno [1,2-c]pyrazol-4-(O-methyl)oxime, were synthesized and, when administered to mice, formed DNA adducts in gastrointestinal tissue. The pattern of these adducts was similar to that obtained with bracken extract and bracken spores and initial co-chromatography experiments indicated that adducts arising from these three compounds could not be resolved. These results suggest that adducts formed in mice treated with bracken extract or spores may have arisen from ptaquiloside, as this compound, as well as 1-(4-chlorophenyl sulphonyl)-l-cyclopropane carbonitrile and 3-cyclopropylindeno [1,2-c]pyrazol-4-(Omethyl)oxime, contains a cyclopropyl ring. However, whether these adducts are in fact derived from the compounds and bracken spores/extract per se or arise via another mechanism, e.g. increased formation of endogenous adducts such as I compounds (Randerath et al., 1986) , remains to be determined. One possible approach to identify these adducts would be to synthesise ptaquiloside-DNA adducts chemically so as to determine whether these adducts are substrates for T4-PNK and can be detected using our assay and chromatographic conditions.
Bracken consumption is associated with increased cancer risk in Japan (Hirayama, 1979) and Brazil (Marliere et al., 1995) . Within the UK, exposure is now almost certainly confined to bracken spores at times when bracken is sporulating. At a site near Caernarfon in North Wales (UK), the bracken spore count in a bracken stand rose from zero levels over the course of 4-5 days to counts of >800 per 1 or >9600 per 1 h'-and then fell to low levels. These values equate to approximately 480 000 spores per hour in the respiratory tidal flow volume. For comparison, when air was sampled in a control, non-bracken area, the count remained low (Heyworth et al., unpublished data; . As part of these exploratory studies, it was also shown that walking for 15 min in a stand of sporulating bracken while wearing a face mask, resulted in deposition on the surface of the filter at the rate of approximately 11 mg of spores h-'. As we have demonstrated that DNA reactive compounds can be released from spores, inhalation of bracken spores may thus provide a significant route of exposure.
In this study, we have also used a modified version of the assay (Shields et al., 1993) in which an internal standard is added to the isolated DNA adducts in order to minimise variations in labelling efficiency and have found that brackeninduced adduct levels were similar whether or not an internal standard was added (Table I ). This is in contrast to previous results in which it was reported that the addition of an internal standard reduced the sensitivity of the assay to detect polycyclic aromatic hydrocarbon adducts (Shields et al., 1993) . This suggests that the bracken-induced adducts are labelled quantitatively in both procedures: the absolute amount of adducts detected, however, remains to be determined, as adduct losses may occur during the DNA extraction, digestion and butanol extraction steps. Rather than measuring the amount of internal standard directly as described previously (on the PEI-cellulose plate before removal of the excess [32P]-y-ATP; Shields et al., 1993) , we have found it simpler to chromatograph a separate aliquot which enables the identification of both [32P]-y-ATP and the internal standard [32P]pdIp (see Figure 3) . Although the actual procedure for quantitation is more complex than the direct measurement of radioactivity incorporated, potentially this approach can allow for variations in labelling efficiency. As we add a known amount of an internal standard into the labelling reaction, we can also directly determine whether the labelling reaction had, in fact, occurred to the extent expected. For example, although we have found that we can detect adducts after extraction of digests of > 10 jig DNA, the reproducibility of adduct.quantitation was poor owing to increased levels of contaminating normal nucleotides that had been coextracted. Under these conditions, labelling of the internal standard was also reduced. This was not a problem, however, with DNA digests containing <4 jug DNA. These observations suggest that addition of an internal standard may aid in increasing the reliability and reproducibility in adduct measurement, even for aromatic adducts.
In summary, we have now shown for the first time that DNA adducts can be detected in rodents treated with either bracken extract or bracken spores using a 32P-post-labelling procedure commonly employed to investigate DNA damage in human populations. As ptaquiloside is a known DNAdamaging agent and is the principal carcinogenic component in bracken, these adducts may arise from the interaction of ptaquiloside with DNA. However, a comparable adduct pattern was observed using two other compounds, whose structures were only similar to ptaquiloside, in that they contained a cyclopropyl ring, suggesting that these compounds and bracken spores/extract may have induced the formation of adducts by an indirect mechanism. As humans are exposed to a large number of potential carcinogens, further work will be necessary to develop methods that are specific for the isolation of bracken-induced DNA adducts, e.g. immunocolumns (Cooper et al., 1992) , before human exposure can be definitively demonstrated and accurately quantified.
Abbreviations MN, micrococcal nuclease; CSPDE, calf spleen phosphodiesterase; dIp, deoxyinosine 3'-monophosphate; pdlp, deoxyinosine 3',5'-bisphosphate; pdNp, 3',5'-bisphosphates of normal nucleosides; T4-PNK, T4-polynucleotide kinase.
